IP Library Granted Patent US 8,933,396
Granted Patent B2
US 8,933,396 · App. 13/805,059 · Granted Jan 13, 2015

Analyte mass spectrometry quantitation using a universal reporter

Inventors: Joel Louette (Ulm, DE); John Charles Rogers (Rockton, IL); Scott M. Peterman (Grimes, IA); Bruno Domon (Strassen, LU); Elodie Duriez (Arlon, BE)
Assignee: Thermo Fisher Scientific GmbH
C07K2/00G01N33/6848G01N33/532B82Y15/00G01N2458/15G01N33/68
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,933,396
App. No.
13/805,059
Granted
Jan 13, 2015
Kind
B2
Abstract

Quantitation of analytes, including but not limited to peptides, polypeptides, and proteins, in mass spectrometry using a labeled peptide coupled to a reporter, and a universal reporter.

Claims (12)

1. A method of generating a dilution curve in a single injection into a liquid chromatograph/mass spectrometer, the method comprising

injecting into a first liquid chromatography (LC) column coupled to a mass spectroscopy detection system a single peptide composition, each peptide in the composition having the identical amino acid sequence A whereby each amino acid is present in the composition as a heavy labeled isomer resulting in the composition being a sequence A blend of all heavy labeled isomers, each isomer in the blend of sequence A having a mass shift and each isomer in the blend of sequence A present in a different concentration,

analyzing each peptide in the co-eluted peptide composition by mass spectroscopy, and

generating from the single peptide composition injection of sequence A into the LC column a dilution curve from the analysis.

2. The method of claim 1 resulting in a decreased loss of the less abundant isomer by non-specific binding to a component of the LC column due to the concentration of the most abundant isomer being higher than the concentration of the most diluted isomer.

3. The method of claim 1 further comprising

injecting at least an additional sequence B and repeating the method, and

comparing the result of analysis of each of the sequence A blend and sequence B blend to compare limits of detection (LOD), and limits of quantitation (LOQ) between different column injections.

4. The method of claim 1 further comprising

injecting the peptide composition from claim 1 into a second liquid chromatography (LC) column coupled to a mass spectroscopy detection system apparatus and repeating the method, and

comparing the result of analysis from each of the first column and second column to compare limits of detection (LOD), and limits of quantitation (LOQ) between different systems.

5. The method of claim 4 wherein the systems are the same brand or are different brands.

Continuity (3)
Continuation In Part PCTUS2011038629 · May 31, 2011
Provisional Application 61361970 · Jul 7, 2010
Related Publication 20130105684A1 · May 2, 2013